CytoReason: New machine learning driven findings uncover new cellular players in tumor micro-environment that might point the way to improved immunotherapy for refractory melanoma patients
Interview with Systems Immunology Expert Prof. Shai Shen-Orr
9 AI-based initiatives catalyzing immunotherapy in 2018
CytoReason’s unique immune-focused AI model creates the largest library of inter-cellular communications – uses it to predict 335 novel cell-cytokine interactions, new clues for drug development
Immune-centric network of cytokines and cells in disease context identified by computational mining of PubMed
AI in Drug Development Podcast – Anchor FM
CytoReason’s Machine-Learning Model Offers New Insights Into Immune-Related Diseases
CytoReason cements proof-of-concept with machine learning-facilitated biomarker breakthrough in anti-TNFα treatment failure in inflammatory bowel disease. New data published in Gut
CytoReason uses AI to personalize drugs, opening the door to cancer treatments
Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD